1. Home
  2. COCP vs HYFM Comparison

COCP vs HYFM Comparison

Compare COCP & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • HYFM
  • Stock Information
  • Founded
  • COCP 2006
  • HYFM 1977
  • Country
  • COCP United States
  • HYFM United States
  • Employees
  • COCP N/A
  • HYFM N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • HYFM Industrial Machinery/Components
  • Sector
  • COCP Health Care
  • HYFM Industrials
  • Exchange
  • COCP Nasdaq
  • HYFM Nasdaq
  • Market Cap
  • COCP 15.4M
  • HYFM 15.0M
  • IPO Year
  • COCP N/A
  • HYFM 2020
  • Fundamental
  • Price
  • COCP $1.07
  • HYFM $2.77
  • Analyst Decision
  • COCP Strong Buy
  • HYFM
  • Analyst Count
  • COCP 1
  • HYFM 0
  • Target Price
  • COCP $6.00
  • HYFM N/A
  • AVG Volume (30 Days)
  • COCP 269.2K
  • HYFM 35.3K
  • Earning Date
  • COCP 11-12-2025
  • HYFM 11-06-2025
  • Dividend Yield
  • COCP N/A
  • HYFM N/A
  • EPS Growth
  • COCP N/A
  • HYFM N/A
  • EPS
  • COCP N/A
  • HYFM N/A
  • Revenue
  • COCP N/A
  • HYFM $161,102,000.00
  • Revenue This Year
  • COCP N/A
  • HYFM N/A
  • Revenue Next Year
  • COCP N/A
  • HYFM $37.86
  • P/E Ratio
  • COCP N/A
  • HYFM N/A
  • Revenue Growth
  • COCP N/A
  • HYFM N/A
  • 52 Week Low
  • COCP $1.02
  • HYFM $1.50
  • 52 Week High
  • COCP $3.26
  • HYFM $8.55
  • Technical
  • Relative Strength Index (RSI)
  • COCP 32.57
  • HYFM 36.29
  • Support Level
  • COCP $1.02
  • HYFM $2.62
  • Resistance Level
  • COCP $1.09
  • HYFM $3.42
  • Average True Range (ATR)
  • COCP 0.07
  • HYFM 0.25
  • MACD
  • COCP -0.01
  • HYFM 0.00
  • Stochastic Oscillator
  • COCP 17.24
  • HYFM 17.44

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.

Share on Social Networks: